Amalgamated Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.58M | Sell |
25,842
-3,920
| -13% | -$750K | 0.04% | 399 |
|
|
2026
Q1 | $5.46M | Sell |
29,762
-523
| -2% | -$96.4K | 0.04% | 384 |
|
|
2025
Q4 | $5.33M | Buy |
30,285
+2,503
| +9% | +$409K | 0.04% | 390 |
|
|
2025
Q3 | $3.89M | Sell |
27,782
-518
| -2% | -$70K | 0.03% | 525 |
|
|
2025
Q2 | $3.55M | Sell |
28,300
-154
| -0.5% | -$19.2K | 0.03% | 539 |
|
|
2025
Q1 | $3.89M | Buy |
28,454
+253
| +0.9% | +$36.2K | 0.03% | 467 |
|
|
2024
Q4 | $4.31M | Sell |
28,201
-422
| -1% | -$71.2K | 0.04% | 452 |
|
|
2024
Q3 | $5.55M | Sell |
28,623
-805
| -3% | -$168K | 0.05% | 355 |
|
|
2024
Q2 | $6.82M | Sell |
29,428
-589
| -2% | -$128K | 0.06% | 287 |
|
|
2024
Q1 | $6.47M | Sell |
30,017
-4,839
| -14% | -$1.13M | 0.06% | 333 |
|
|
2023
Q4 | $9.02M | Sell |
34,856
-2,897
| -8% | -$712K | 0.07% | 249 |
|
|
2023
Q3 | $9.7M | Buy |
37,753
+993
| +3% | +$266K | 0.08% | 203 |
|
|
2023
Q2 | $10.5M | Sell |
36,760
-934
| -2% | -$278K | 0.08% | 196 |
|
|
2023
Q1 | $10.5M | Sell |
37,694
-81
| -0.2% | -$22.4K | 0.09% | 189 |
|
|
2022
Q4 | $10.5M | Buy |
37,775
+547
| +1% | +$154K | 0.09% | 184 |
|
|
2022
Q3 | $9.94M | Buy |
37,228
+406
| +1% | +$86.2K | 0.1% | 171 |
|
|
2022
Q2 | $7.51M | Sell |
36,822
-43
| -0.1% | -$8.79K | 0.07% | 247 |
|
|
2022
Q1 | $7.76M | Sell |
36,865
-2,667
| -7% | -$580K | 0.06% | 284 |
|
|
2021
Q4 | $9.48M | Sell |
39,532
-771
| -2% | -$198K | 0.07% | 244 |
|
|
2021
Q3 | $11.4M | Sell |
40,303
-2,182
| -5% | -$715K | 0.1% | 169 |
|
|
2021
Q2 | $14.7M | Buy |
42,485
+33,857
| +392% | +$10.3M | 0.12% | 140 |
|
|
2021
Q1 | $2.41M | Sell |
8,628
-430
| -5% | -$116K | 0.09% | 177 |
|
|
2020
Q4 | $2.22M | Sell |
9,058
-291
| -3% | -$75.1K | 0.08% | 200 |
|
|
2020
Q3 | $2.65M | Sell |
9,349
-525
| -5% | -$146K | 0.12% | 144 |
|
|
2020
Q2 | $2.64M | Sell |
9,874
-16,862
| -63% | -$5.07M | 0.12% | 136 |
|
|
2020
Q1 | $8.46M | Sell |
26,736
-1,859
| -7% | -$564K | 0.21% | 98 |
|
|
2019
Q4 | $8.48M | Sell |
28,595
-45
| -0.2% | -$12.5K | 0.16% | 121 |
|
|
2019
Q3 | $6.67M | Buy |
28,640
+1,552
| +6% | +$361K | 0.14% | 137 |
|
|
2019
Q2 | $6.33M | Sell |
27,088
-2,605
| -9% | -$602K | 0.15% | 128 |
|
|
2019
Q1 | $7.02M | Buy |
29,693
+308
| +1% | +$97K | 0.17% | 109 |
|
|
2018
Q4 | $8.84M | Sell |
29,385
-857
| -3% | -$273K | 0.25% | 73 |
|
|
2018
Q3 | $10.7M | Sell |
30,242
-2,371
| -7% | -$816K | 0.26% | 71 |
|
|
2018
Q2 | $9.47M | Buy |
32,613
+1,828
| +6% | +$514K | 0.23% | 77 |
|
|
2018
Q1 | $8.43M | Buy |
30,785
+2,838
| +10% | +$881K | 0.22% | 81 |
|
|
2017
Q4 | $8.9M | Buy |
27,947
+2,452
| +10% | +$787K | 0.24% | 77 |
|
|
2017
Q3 | $7.98M | Buy |
25,495
+496
| +2% | +$147K | 0.25% | 76 |
|
|
2017
Q2 | $6.78M | Buy |
24,999
+8,426
| +51% | +$2.23M | 0.22% | 85 |
|
|
2017
Q1 | $4.53M | Sell |
16,573
-7,128
| -30% | -$2.02M | 0.23% | 77 |
|
|
2016
Q4 | $6.72M | Buy |
23,701
+4,115
| +21% | +$1.22M | 0.3% | 62 |
|
|
2016
Q3 | $6.13M | Buy |
19,586
+5
| +0% | +$1.48K | 0.36% | 53 |
|
|
2016
Q2 | $6.16M | Buy |
19,581
+10,751
| +122% | +$2.83M | 0.36% | 57 |
|
|
2016
Q1 | $2.3M | Buy |
8,830
+2,082
| +31% | +$550K | 0.22% | 73 |
|
|
2015
Q4 | $2.07M | Sell |
6,748
-2,183
| -24% | -$627K | 0.26% | 57 |
|
|
2015
Q3 | $2.61M | Buy |
8,931
+328
| +4% | +$108K | 0.27% | 58 |
|
|
2015
Q2 | $3.48M | Buy |
8,603
+335
| +4% | +$134K | 0.34% | 43 |
|
|
2015
Q1 | $3.49M | Buy |
8,268
+1,903
| +30% | +$750K | 0.43% | 45 |
|
|
2014
Q4 | $2.16M | Sell |
6,365
-923
| -13% | -$299K | 0.34% | 52 |
|
|
2014
Q3 | $2.41M | Buy |
7,288
+442
| +6% | +$146K | 0.36% | 49 |
|
|
2014
Q2 | $2.16M | Buy |
6,846
+788
| +13% | +$237K | 0.33% | 53 |
|
|
2014
Q1 | $1.85M | Sell |
6,058
-121
| -2% | -$38.4K | 0.32% | 54 |
|
|
2013
Q4 | $1.73M | Buy |
+6,179
| New | +$1.6M | 0.29% | 60 |
|
Other funds holding BIIB
AIM
Amalgamated Bank's BIIB Position: Q2 2026 in Review
Amalgamated Bank reduced its Biogen (BIIB) stake by 13% in Q2 2026, selling an estimated $750K and leaving 25,842 shares worth $5.58M. The position accounts for 0.04% of the portfolio, ranked #399.
Amalgamated Bank first reported a position in BIIB in Q4 2013 and has held it in 51 quarters since. The position peaked at $14.7M in Q2 2021. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Amalgamated Bank held 25,842 shares of Biogen worth $5.58M as of Q2 2026.
- Amalgamated Bank sold 3,920 Biogen shares in Q2 2026, an estimated $750K.
- Biogen made up 0.04% of Amalgamated Bank's portfolio in Q2 2026, its #399 holding.
- Amalgamated Bank first reported a position in Biogen in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Biogen position peaked at $14.7M in Q2 2021.
- 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.